COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 721: Articles 7201-7210  | Next

Multiple effects of TNFα inhibitors on the development of the adaptive immune response after SARS-CoV-2 vaccination
Geisen, U. M., Rose, R., Neumann, F., Ciripoi, M., Vullriede, L., Reid, H. M., Berner, D. K., Bertoglio, F., Hoff, P., Hust, M., Longardt, A. C., Lorentz, T., Rios Martini, G., Saggau, C., Schirmer, J. H., Schubert, M., Suembuel, M., Tran, F., Voss, M., Zeuner, R., Morrison, P. J., Bacher, P., Fickenscher, H., Gerdes, S., Peipp, M., Schreiber, S., Krumbholz, A., Hoyer, B. F.
10.1101/2022.07.01.22277143 — Posted: 2022-07-03
Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
Wadhwa, B., Malhotra, V., Kerai, S., Husain, F., Pandey, N. B., Saxena, K. N., Singh, V., Quinn, T. M., Li, F., Gaughan, E., Shankar-Hari, M., Mills, B., Antonelli, J., Bruce, A., Finlayson, K., Moore, A., Dhaliwal, K., Edwards, C.
10.1101/2022.07.01.22277163 — Posted: 2022-07-02
Self-Reported Use of COVID-19 Immunologic Test Results to Inform Decisions About Daily Activities and COVID-19 Vaccination
Jiang, M., Akers, N. K., Gill, D. B., Eckhert, B., Svejnoha, E., Robins, H. S.
10.1101/2022.07.01.22277108 — Posted: 2022-07-02
The changing landscape of respiratory viruses contributing to respiratory hospitalisations: results from a hospital-based surveillance in Quebec, Canada, 2012-13 to 2021-22
Gilca, R., Amini, R., Carazo, S., Frenette, C., Boivin, G., Charest, H., Dumaresq, J.
10.1101/2022.07.01.22277061 — Posted: 2022-07-02
DIFFERENTIAL SARS-COV-2 ANTIGEN SPECIFICITY OF THE HUMORAL RESPONSE IN INACTIVATED VIRUS-VACCINATED, CONVALESCENT, AND BREAKTHROUGH SUBJECTS
Duarte, L. F., Vasquez, Y., Diethelm-Varela, B., Pavez, V., Berrios-Rojas, R., White, J. A., Kalergis, A. M., Bueno, S. M., Gonzalez, P. A.
10.1101/2022.07.01.22277165 — Posted: 2022-07-02
Pre-existing population immunity and SARS-CoV-2 variant establishment and dominance dynamics in the United States: An ecological study
Ankomah, P. O., Siedner, M., Bhattacharyya, R.
10.1101/2022.07.01.22277157 — Posted: 2022-07-02
Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models
Whittaker, D. G., Herrera-Reyes, A. D., Hendrix, M., Owen, M. R., Band, L. R., Mirams, G. R., Bolton, K. J., Preston, S. P.
10.1101/2022.07.01.22277134 — Posted: 2022-07-02
Increased disparity in routine infant vaccination during COVID-19
Righolt, C., Pabla, G., Mahmud, S.
10.1101/2022.06.30.22277115 — Posted: 2022-07-02
Rucaparib blocks SARS-CoV-2 virus binding to cells and interleukin-6 release in a model of COVID-19
Papp, H., Bovari-Biri, J., Banfai-Biri, K., Juhasz, P., Mahdi, M., Russo, L. C., Bajusz, D., Sipos, A., Petri, L., Kemeny, A., Madai, M., Kuczmog, A., Batta, G., Mozner, O., Vasko, D., Hirsch, E., Bohus, P., Mehes, G., Tozser, J., Curtin, N. J., Helyes, Z., Toth, A., Hoch, N., Jakab, F., Keseru, G., Pongracz, J. E., Bai, P.
10.1101/2022.06.30.22277079 — Posted: 2022-07-02
The decline of COVID-19 severity and lethality over two years of pandemic
Marziano, V., Guzzetta, G., Menegale, F., Sacco, C., Petrone, D., Urdiales, A. M., Del Manso, M., Bella, A., Fabiani, M., Vescio, M. F., Riccardo, F., Poletti, P., Manica, M., Zardini, A., d'Andrea, V., Trentini, F., Stefanelli, P., Rezza, G., Palamara, A. T., Brusaferro, S., Ajelli, M., Pezzotti, P., Merler, S.
10.1101/2022.07.01.22277137 — Posted: 2022-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).